Role of oncogenic K-Ras in cancer stem cell activation by aberrant wnt/β-catenin signaling

Journal of the National Cancer Institute

Volumn 106, Issue 2, 2014, Pages

  Moon, Byoung San ^a   Jeong, Woo Jeong ^a   Park, Jieun ^a   Kim, Tae Il ^a   Min, Do Sik ^a,b   Choi, Kang Yell ^a  

^a Yonsei University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALCAM PROTEIN, HUMAN; APC PROTEIN; APC PROTEIN, HUMAN; BETA CATENIN; CD133 ANTIGEN; CD44 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; FETOPROTEIN; GLYCOPROTEIN; HERMES ANTIGEN; KRAS PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; NERVE CELL ADHESION MOLECULE; ONCOPROTEIN; PEPTIDE; RAS PROTEIN; WNT PROTEIN;

ADULT; AGED; ANIMAL; ARTICLE; CANCER STEM CELL; CELL TRANSFORMATION; COLON POLYPOSIS; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; MUTATION; ONCOGENE RAS; PATHOLOGY; SIGNAL TRANSDUCTION; SOUTH KOREA; XENOGRAFT;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; BETA CATENIN; CELL ADHESION MOLECULES, NEURONAL; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GLYCOPROTEINS; HETEROGRAFTS; HUMANS; MALE; MICE; MIDDLE AGED; MUTATION; NEOPLASTIC STEM CELLS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; REPUBLIC OF KOREA; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84893851756     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt373     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Pang R, Law WL, Chu AC, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 2010;6(6):603-615.
3. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559-1564.
4. Schepers AG, Snippert HJ, Stange DE, et al., Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science. 2012;337(6095):730-735.
5. Dalerba P, Clarke MF. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell. 2007;1(3):241-242.
6. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445(7123):106-110.
7. Vermeulen L, De Sousa E M F, Van Der Heijden M, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12(5):468-476.
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159-170.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-767.
10. Van De Wetering M, Sancho E, Verweij C, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111(2):241-250.
11. Salic A, Lee E, Mayer L, Kirschner MW. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell. 2000;5(3):523-532.
12. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781-810.
13. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19(4):379-383.
14. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol. 2009;217(2):307-317.
15. Lewis A, Segditsas S, Deheragoda M, et al., Severe polyposis in Apc (1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5. Gut. 2010;59(12):1680-1686.
16. Li J, Chen B. Oct4 was a novel target of Wnt signaling pathway. Mol Cell Biochem. 2012;362(1-2):233-240.
17. Janssen KP, Alberici P, Fsihi H, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology. 2006;131(4):1096-1109.
18. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108-1113.
19. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704-715.
20. Nash GM, Gimbel M, Shia J, et al. KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases. Ann Surg Oncol. 2010;17(2):572-578.
21. Kemper K, Grandela C, Medema JP. Molecular identification and targeting of colorectal cancer stem cells. Oncotarget. 2010;1(6):387-395.
22. Jeong WJ, Yoon J, Park JC, et al. Ras stabilization through aberrant activation of Wnt/beta-catenin signaling promotes intestinal tumorigenesis. Sci Signal. 2012;5(219): ra30.
23. Moon BS, Kim HY, Kim MY, et al. Sur8/Shoc2 involves both inhibition of differentiation and maintenance of self-renewal of neural progenitor cells via modulation of extracellular signal-regulated kinase signaling. Stem Cells. 2011;29(2):320-331.
24. Yun J, Rago C, Cheong I, et al., Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325(5947):1555-1559.
25. Vermeulen L, Todaro M, De Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A. 2008;105(36):13427-13432.
26. Yoon J, Koo KH, Choi KY. MEK1/2 inhibitors AS703026 and AZD6244 may be potential therapies for KRAS mutated colorectal cancer that is resistant to EGFR monoclonal antibody therapy. Cancer Res. 2011;71(2):445-453.
27. Oudejans JJ, Slebos RJ, Zoetmulder FA, Mooi WJ, Rodenhuis S. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. Int J Cancer. 1991;49(6):875-879.
28. Todaro M, Alea MP, Di Stefano AB, et al., Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell. 2007;1(4):389-402.
29. Lee SH, Hu LL, Gonzalez-Navajas J, et al. ERK activation drives intestinal tumorigenesis in Apc (min/+) mice. Nat Med. 2010;16(6):665-670.
30. Horst D, Chen J, Morikawa T, et al. Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling. Cancer Res. 2012;72(6):1547-1556.
31. Singh K, Deshpande P, Li G, et al. K-RAS GTPase- and B-RAF kinasemediated T-cell tolerance defects in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2012;109(25):E1629-1637.